Modularly Designed Peptide Nanoprodrug Augments Antitumor Immunity of PD-L1 Checkpoint Blockade by Targeting Indoleamine 2,3-Dioxygenase
Xuexiang Han(National Center for Nanoscience and Technology), Yiye Li(National Center for Nanoscience and Technology), Guangjun Nie(National Center for Nanoscience and Technology), Keman Cheng(Xiamen University), Huan Min(National Center for Nanoscience and Technology), Gregory J. Anderson(QIMR Berghofer Medical Research Institute), Ying Xu(Case Western Reserve University), Yinlong Zhang(Sino-Danish Centre for Education and Research), Lei Ren(Nanjing Normal University), Ruifang Zhao(National Engineering Research Center for Nanotechnology), Yazhou Wang(Air Force Medical University), Xiao Zhao(Institute of Genetics and Developmental Biology)
Cited by 131
Related Papers
An ionizable lipid toolbox for RNA delivery
|Nature Communications|2021|581
Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology
|Nature Communications|2021|449
Precise nanomedicine for intelligent therapy of cancer
|Science China Chemistry|2018|413
Surface Design for Antibacterial Materials: From Fundamentals to Advanced Strategies
|Advanced Science|2021|407
PCR Past, Present and Future
|BioTechniques|2020|360